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OBJECTIVES The goal of this study was to determine whether postprandial hyperglycemia, induced by oral
glucose loading, attenuates endothelial function in healthy subjects without diabetes and
whether coadministration of vitamins C and E could prevent these postprandial changes.
BACKGROUND Epidemiologic evidence suggests that postprandial hyperglycemia, below diabetic levels, is a
risk factor for cardiovascular disease. Postprandial hyperglycemia may promote atherosclerosis
through endothelial dysfunction and oxidative stress.
METHODS We evaluated the acute effects of oral glucose loading (75 g), alone and with vitamins C (2 g)
and E (800 IU), on endothelium-dependent flow-mediated dilation (FMD) of the brachial
artery, in a randomized, double-blind, placebo-controlled, crossover study of 10 healthy
volunteers. Changes in the levels of markers of oxidative stress (plasma malondialdehyde and
erythrocyte glutathione, glutathione peroxidase and superoxide dismutase) were also assessed.
RESULTS Increases in plasma glucose and insulin after glucose loading were unaffected by vitamin
coadministration. With glucose loading alone, FMD fell from 6.5 6 2.2 at baseline to 5.4 6
1.7, 3.7 6 2.1*, 4.1 6 3.5* and 5.7 6 1.9% at 1, 2, 3 and 4 h (*p , 0.05 vs. 0 h). In contrast,
FMD did not change significantly after glucose plus vitamins (6.4 6 1.3, 7.6 6 1.8, 7.9 6
2.7, 6.9 6 2.3, 6.9 6 1.9% at 0, 1, 2, 3 and 4 h). By two-way repeated measures analysis of
variance we found a significant interaction between vitamin treatment and time (p 5 0.0003),
indicating that vitamins prevented the glucose-induced attenuation of FMD. Oxidative stress
markers did not significantly change with glucose loading alone or with vitamins.
CONCLUSIONS Oral glucose loading causes an acute, transient decrease of FMD in healthy subjects without
diabetes, which is prevented by vitamins C and E. (J Am Coll Cardiol 2000;36:2185–91) ©
2000 by the American College of Cardiology
Diabetes mellitus is a well-established risk factor for car-
diovascular disease (1). Increasingly, it has been suggested
that postprandial hyperglycemia, at levels well below the
cutoff for diabetes or impaired glucose tolerance (IGT), is
also a risk factor for the development of cardiovascular
disease (2–5). For example, several prospective epidemio-
logic studies of populations without diabetes, such as the
Whitehall Study (6), Honolulu Heart Study (7) and Hel-
sinki Policeman Study (8) have demonstrated that postpran-
dial plasma glucose levels as low as 5.4 mmol/L are
associated with an increased risk of eventual cardiovascular
mortality. In fact, a meta-analysis of 20 published studies of
nondiabetic cohorts indicates that there is a continuous and
graded relationship between increasing fasting or postpran-
dial glucose levels and the risk of cardiovascular events, with
no apparent threshold (5).
The mechanisms by which postprandial hyperglycemia
may promote atherosclerosis remain unknown. Evidence
from in vitro studies suggests that hyperglycemia leads to
increased generation of oxygen free radicals, such as super-
oxide anion, which may cause endothelial cell injury and
inactivation of endothelial-derived nitric oxide (NO) (9–
12). As a result, hyperglycemia causes endothelial cell
dysfunction, which is a key step in the development of
atherosclerosis (13). In humans, there is evidence that both
type I and II diabetes mellitus are associated with impaired
endothelium-dependent vasodilation (14,15) and increased
oxidative stress (16,17). Even transient increases in plasma
glucose may cause an acute impairment in endothelial
function in healthy subjects without diabetes (18–20). As
well, postprandial hyperglycemia, induced by oral glucose
loading, may cause an acute oxidant stress in healthy
subjects with normal glucose tolerance (20–23). Thus, it is
plausible that repeated spikes in postprandial hyperglycemia
may stimulate atherogenesis through endothelial dysfunc-
tion and oxidative stress (4,24).
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In vitro studies suggest that various antioxidants, includ-
ing vitamins C and E, may prevent hyperglycemia-induced
endothelial injury or dysfunction (9,12,25,26). In humans,
acute administration of vitamin C improves endothelium-
dependent vasodilation for patients with type II diabetes
(27). Therefore, there may be a rationale for the use of
vitamins C and E to reverse the vascular effects of hyper-
glycemia.
Accordingly, the purpose of this study was to confirm
whether postprandial hyperglycemia, induced by an oral
glucose load, attenuates endothelium-dependent flow-
mediated dilation (FMD) and causes increased oxidative
stress in healthy subjects without diabetes and to determine
the time course of any such effects. Secondly, we examined
whether coadministration of vitamins C and E could pre-
vent these postprandial changes in endothelial function.
METHODS
Subjects. Ten healthy nondiabetic volunteers (6 men, 4
women), aged 20 to 30 years, were recruited from the
hospital staff and associated university. All individuals were
nonsmokers, normotensive and had total cholesterol , 6.2
mmol/L. None of the subjects had clinical evidence or a
family history of premature cardiovascular disease. None of
the subjects were taking medications or vitamin supple-
ments. All subjects gave informed consent before participa-
tion. The study protocol was approved by the Research
Ethics Committee of the Queen Elizabeth II Health
Sciences Center.
Study design. The acute effects of oral glucose loading,
with and without vitamins C and E, on FMD was studied
in a randomized, double-blind, placebo-controlled, cross-
over design. All subjects were studied on two mornings,
separated by 1 week. Individuals were randomized to receive
1 of 2 loads during the first study: 1) an oral glucose load
(75 g glucose; Glucodex, Rougier, Chambly, Quebec, Can-
ada) immediately followed by oral ingestion of placebo
vitamins or 2) the same oral glucose load immediately
followed by oral ingestion of vitamin C (2 g) and vitamin E
(800 IU d-alpha-tocopheryl acetate). Subjects received the
alternative load during the second study on the following
week. The vitamins were administered in a double-blind
fashion, with matching placebo capsules. The doses of
vitamins C and E were selected because similar doses had
been shown to reverse postprandial endothelial dysfunction
after high fat or methionine loading (28,29).
Both studies were performed after a 12 h overnight fast.
Caffeine and alcohol were avoided for 12 h before each
study. During each study an indwelling venous catheter was
inserted into the left antecubital vein for repeated venous
blood samples. After at least 10 min rest, baseline blood
samples for plasma glucose, insulin, serum lipids and mark-
ers of oxidative stress (including plasma malondialdehyde as
a marker of lipid peroxidation and erythrocyte levels of the
antioxidants: glutathione, glutathione peroxidase and super-
oxide dismutase [SOD]) were collected, and FMD mea-
surements were performed at “time 0”. Subjects then re-
ceived their randomly assigned load, and serial blood
samples and FMD measurements were obtained at 1, 2, 3
and 4 h after glucose loading.
Noninvasive endothelium-dependent FMD assessment.
Endothelium-dependent FMD of the brachial artery was
assessed noninvasively using a high-resolution ultrasound
system (Hewlett-Packard SONOS 2500, Agilent Technol-
ogies, Palo Alto, California) with a 7.5 MHz linear-array
vascular transducer, as previously described (30,31). Briefly,
a pneumatic tourniquet placed proximally on the forearm
was inflated to 250 mm Hg pressure for 5 min and rapidly
deflated, resulting in reactive hyperemia. Brachial artery
images were obtained at baseline and 1 min after cuff
deflation to assess the change in brachial artery diameter in
response to reactive hyperemia. This procedure was repeated
at 1, 2, 3 and 4 h after glucose ingestion.
End-diastolic frames (coincident with the electrocardio-
graphic R wave) from four consecutive cardiac cycles of the
serial baseline and 1 min after reactive hyperemia phases (at
time 0, 1, 2, 3 and 4 h) were digitized and analyzed by one
observer, blinded to the load assignment and the protocol
phase, as previously described (31). Endothelium-
dependent FMD was calculated as the percent change in
brachial artery diameter 1 min after reactive hyperemia
compared with baseline at each time phase of the protocol
(time 0, 1, 2, 3 and 4 h, within subject coefficient of
variation—2.1%). Brachial artery flow and reactive hyper-
emia were estimated using velocity time integrals and
brachial artery diameters, as previously described (30,31).
Biochemistry analyses. Venous blood was collected in
EDTA tubes (for plasma glucose, insulin, malondialdehyde
and erythrocyte glutathione, glutathione peroxidase and
SOD) and in serum separating gel tubes (for serum lipids)
and immediately placed on ice. Plasma was separated within
15 min and frozen at 270°C for subsequent analysis. After
removal of plasma, erythrocyte samples were obtained by
washing the remaining cells and then by repeated centrifu-
gation to remove the liquid and buffy coat. The remaining
packed erythrocytes were diluted with 9 parts ice-cold
distilled water. These diluted (10%) erythrocyte aliquots
were frozen at 270°C for subsequent analysis for glutathi-
one, glutathione peroxidase and SOD levels.
Plasma glucose and serum lipids were measured with a
Beckman Synchron CX7 system. Plasma insulin levels were
measured with a commercial radioimmunoassay kit (Phad-
Abbreviations and Acronyms
ANOVA 5 analysis of variance
FMD 5 flow-mediated dilation
IGT 5 impaired glucose tolerance
IRCM 5 Institut de recherches cliniques de Montre´al
NO 5 nitric oxide
SOD 5 superoxide dismutase
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eseph Insulin RIA, Pharmacia & Upjohn Diagnostics AB,
Uppsala, Sweden). Plasma malondialdehyde was measured
by high-performance liquid chromatography, as described
by Fukunaga et al. (32). Erythrocyte glutathione was mea-
sured at Institut de recherches cliniques de Montre´al
(IRCM) by high-performance liquid chromatography and
fluorescence detection, as described by Durand et al. (33),
and results are expressed as mM/g of hemoglobin. Erythro-
cyte glutathione peroxidase and SOD levels were measured
at IRCM using commercial kits (RANSEL and RANSOD,
Randox Laboratories, Mississauga, Ontario), and results are
expressed as U/g of hemoglobin. Serial erythrocyte gluta-
thione peroxidase and SOD levels were measured in dupli-
cate, and the results were averaged.
Statistical analysis. The effects of oral glucose loading,
with and without vitamins, on plasma glucose, insulin,
markers of oxidative stress and FMD were analyzed by
repeated measures, one-way analysis of variance (ANOVA).
Changes in these parameters over time were compared for
glucose alone versus glucose plus vitamins by repeated
measures, two-way ANOVA, with each patient acting as his
own control in this crossover study. If differences reached
statistical significance, post hoc analyses with a two-tailed
paired t test was used to assess differences at individual time
periods in the study, using a Bonferroni correction for
multiple comparisons. Linear regression was used to assess
the relationship between the change in FMD and the
postprandial change in plasma glucose and insulin levels.
Two-sided p values less than 0.05 were considered to
indicate statistical significance. Continuous data are ex-
pressed as means 6 standard deviation, unless stated oth-
erwise.
RESULTS
The baseline characteristics of the 10 study subjects are
shown in Table 1. Baseline blood pressure, fasting serum
lipids, fasting glucose and FMD (forearm occlusion) were
normal and were similar on both studies.
The effects of glucose loading, alone and with vitamins,
on plasma glucose, insulin and serum lipids are shown in
Table 2. Plasma glucose and insulin levels increased at 1 h
postprandial and returned to baseline levels by 4 h with oral
glucose loading alone. Of note, all subjects had a 2 h
postprandial glucose level below the cutoff for IGT (7.8
mmol/L). Coadministration of vitamins C and E did not
significantly affect the increase in plasma glucose and insulin
levels after glucose loading. Serum lipids were unaltered
after glucose loading, alone and with vitamins.
As seen in Table 3, heart rate, blood pressure, basal
brachial artery diameter, basal brachial artery flow and
reactive hyperemia did not change significantly after glucose
loading, with or without vitamins.
The effects of glucose loading, alone and with vitamins,
Table 1. Baseline Clinical Characteristics of the Study Subjects
Characteristic n 5 10
Age (yr) 25.5 6 3.1
Men/Women 6/4
Body mass index (kg/m2) 24 6 3
Systolic BP (mm Hg) 118 6 8
Diastolic BP (mm Hg) 72 6 7
Heart rate (min21) 63 6 8
Total cholesterol (mmol/L) 5.1 6 1.1
HDL-cholesterol (mmol/L) 1.3 6 0.1
LDL-cholesterol (mmol/L) 3.3 6 0.9
Triglycerides (mmol/L) 1.2 6 0.5
Fasting glucose (mmol/L) 5.3 6 0.7
Basal brachial artery diameter (mm) 3.59 6 0.58
Baseline FMD (%) 7.0 6 2.2
BP 5 blood pressure; FMD 5 flow-mediated dilatation; HDL 5 high-density
lipoprotein; LDL 5 low-density lipoprotein.
Table 2. Glucose, Insulin and Lipid Values Before and After Oral Glucose Loading, Alone or
With Vitamins
Variable 0 h 1 h 2 h 3 h 4 h p Value
Plasma glucose–mmol/L
Glucose 5.2 6 0.7 7.9 6 3.0 5.8 6 1.9 4.5 6 1.3 4.6 6 0.5
Glucose 1 vitamins 5.5 6 0.4 8.3 6 2.4 6.2 6 1.4 4.7 6 0.6 5.0 6 0.5 0.99
Plasma insulin—mIU/L
Glucose 6.9 6 2.5 69.8 6 44.2 38.2 6 26.5 13.4 6 14.5 6.6 6 2.3
Glucose 1 vitamins 5.9 6 1.1 53.6 6 27.2 30.2 6 14.6 9.2 6 4.3 6.7 6 2.5 0.35
Total cholesterol—mmol/L
Glucose 5.1 6 1.0 4.9 6 0.9 4.8 6 0.9 5.0 6 0.9 5.0 6 0.9
Glucose 1 vitamins 5.0 6 0.7 4.8 6 0.6 4.7 6 0.6 4.8 6 0.6 4.8 6 0.7 0.74
LDL-cholesterol—mmol/L
Glucose 3.3 6 0.9 3.2 6 0.8 3.2 6 0.9 3.3 6 0.9 3.4 6 0.9
Glucose 1 vitamins 3.2 6 0.5 3.0 6 0.5 3.0 6 0.5 3.1 6 0.5 3.1 6 0.6 0.14
HDL-cholesterol—mmol/L
Glucose 1.3 6 0.1 1.2 6 0.2 1.2 6 0.2 1.3 6 0.2 1.3 6 0.2
Glucose 1 vitamins 1.3 6 0.1 1.3 6 0.2 1.2 6 0.2 1.3 6 0.2 1.2 6 0.2 0.11
Triglycerides—mmol/L
Glucose 1.2 6 0.5 1.1 6 0.4 0.9 6 0.4 0.9 6 0.3 0.8 6 0.3
Glucose 1 vitamins 1.1 6 0.5 1.1 6 0.5 1.0 6 0.4 0.9 6 0.5 0.9 6 0.5 0.10
HDL 5 high-density lipoprotein; LDL 5 low-density lipoprotein.
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on FMD are shown in Figure 1. Flow-mediated dilation
significantly fell from 6.5 6 2.2% at baseline to 3.7 6 2.1%
at 2 h postprandial and returned towards baseline by 4 h
with glucose loading alone (p 5 0.002 by one-way
ANOVA). In contrast, FMD did not change significantly
in response to glucose plus vitamins (p 5 0.20 by one-way
ANOVA). Using two-way repeated measures ANOVA
(treatment group vs. time), we found a significant treatment
group effect (p 5 0.0016) but no significant time effect (p 5
0.28). There was a significant interaction between treatment
group and time (p 5 0.0003), indicating that there was a
significant difference between glucose alone versus glucose
with vitamins with regard to the change in FMD. Thus,
vitamins C and E prevented the acute attenuation of FMD
induced by glucose loading. Accordingly, the mean change
in FMD seen at 2 h postprandial compared with preprandial
endothelial function was significantly different for glucose
alone versus glucose with vitamins (Fig. 2). The change in
FMD induced by glucose loading did not correlate to the
postprandial change in plasma glucose or insulin levels.
As shown in Table 4, the systemic markers of oxidative
stress did not change significantly with glucose loading
alone or with the coadministration of vitamins C and E.
DISCUSSION
The major findings of this study are: 1) oral glucose loading
causes an acute, transient attenuation of endothelium-
dependent FMD in healthy subjects without diabetes and 2)
Figure 1. Effects of oral glucose loading alone, (solid circle), or with
vitamins C and E, (open circle) on flow-mediated dilatation (FMD;
mean 6 SE) over 4 h. Vitamins C and E prevented the acute attenuation
of FMD seen with glucose loading alone (p 5 0.0003 by two-way analysis
of variance for response of glucose alone versus glucose with vitamins).
*p , 0.05 compared with FMD at baseline (0 h); †p , 0.05 compared with
glucose with vitamins at 2 h.
Figure 2. Mean change in flow-mediated dilatation (FMD) at 2 h
postprandial compared with preprandial FMD for glucose loading alone
(solid bar) versus glucose loading plus vitamins (open bar). The bars
represent mean 6 standard error. *p 5 0.001 for glucose alone versus
glucose with vitamins.
Table 3. Hemodynamics, Basal Brachial Artery Diameters, Brachial Artery Flow and Reactive Hyperemia Before and After Oral
Glucose Loading, Alone or With Vitamins
Basal Hemodynamics 0 h 1 h 2 h 3 h 4 h p Value
Systolic blood pressure (mm Hg)
Glucose 117 6 8 116 6 8 114 6 8 112 6 8 114 6 11
Glucose 1 vitamins 116 6 10 120 6 9 113 6 10 113 6 10 116 6 9 0.32
Diastolic blood pressure (mm Hg)
Glucose 71 6 7 69 6 9 70 6 7 67 6 7 71 6 10
Glucose 1 vitamins 73 6 8 70 6 10 69 6 10 71 6 10 71 6 10 0.29
Heart rate (min21)
Glucose 63 6 9 64 6 8 63 6 9 60 6 9 64 6 9
Glucose 1 vitamins 62 6 8 62 6 8 59 6 8 59 6 7 58 6 6 0.11
Basal brachial artery diameter (mm)
Glucose 3.58 6 0.63 3.62 6 0.61 3.64 6 0.67 3.62 6 0.62 3.60 6 0.59
Glucose 1 vitamins 3.61 6 0.58 3.66 6 0.57 3.65 6 0.53 3.64 6 0.57 3.58 6 0.54 0.63
Basal brachial artery flow (ml/min)
Glucose 134 6 105 108 6 116 85 6 45 106 6 96 89 6 58
Glucose 1 vitamins 100 6 69 107 6 89 90 6 67 88 6 75 76 6 41 0.10
Reactive hyperemia (%)
Glucose 421 6 195 614 6 240 595 6 83 544 6 275 596 6 149
Glucose 1 vitamins 582 6 180 576 6 290 646 6 201 656 6 193 729 6 327 0.65
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coadministration of vitamins C and E prevented this post-
prandial change in endothelial function.
Effect of glucose loading on endothelial function. It is
well established that diabetes is associated with impaired
endothelium-dependent vasodilation (14,15). However,
even acute hyperglycemia may attenuate endothelium-
dependent vasodilation in subjects without diabetes (18–
20). Williams et al. (18) first demonstrated that 6 h of local
hyperglycemia (16.7 mmol/L) induced by glucose clamping
impaired endothelium-dependent vasodilation in humans
without diabetes. Similar findings were found when oct-
reotide was coadministered to block the release of insulin,
suggesting that these vascular effects were mediated by
hyperglycemia, rather than hyperinsulinemia. Recently, it
has been demonstrated that mild increases in postprandial
glucose levels may alter endothelial function. For example,
Akbari et al. (19) demonstrated that ingestion of 75 g of
glucose by healthy subjects without diabetes could decrease
FMD after 1 h. Similarly, Kawano et al. (20) demonstrated
that FMD decreased within 1 h of oral glucose loading in
subjects with normal glucose tolerance, IGT and diabetes.
However, the degree of postprandial impairment was
greater with IGT and diabetes than it was with normal
glucose tolerance. In that study there was a negative
correlation between FMD and plasma glucose, suggesting
that there is a continuous and graded relationship between
increasing glucose levels and decreasing endothelial func-
tion. Our results confirm these observations because FMD
was significantly attenuated 2 h after oral glucose loading
and returned towards baseline by 4 h. Similar to the
previous studies, this change in endothelial function oc-
curred at relatively low levels of postprandial hyperglycemia,
which was below the cutoff for IGT and diabetes. Unlike
Kawano et al. (20) we did not find any relationship between
endothelial function and plasma glucose although our study
was confined to subjects with normal glucose tolerance and
had fewer subjects.
Potential mechanisms for endothelial dysfunction after
glucose loading. Flow-mediated dilation of the brachial
artery has been shown to be dependent upon the release of
endothelium-derived NO (34). Therefore, our findings
imply that the oral glucose loading may lead to a transient
loss of NO bioavailability, which may be a consequence of
either decreased NO formation or increased NO inactiva-
tion. In vitro studies suggest that the exposure of endothelial
cells to elevated glucose levels leads to the generation of
oxygen free radicals, such as superoxide anion, which may
inactivate NO or contribute to endothelial cell injury (9–
12).
In humans, there is evidence that hyperglycemia is
associated with increased oxidative stress. Patients with
diabetes mellitus have increased levels of lipid peroxidation
and reduced levels of endogenous antioxidants compared
with controls (16,17). Moreover, acute oral glucose loading
can cause an acute oxidant stress in healthy, subjects without
diabetes (20–23). In contrast, our study failed to demon-
strate any significant changes in a number of systemic
markers of oxidative stress, including malondialdehyde,
erythrocyte SOD, glutathione and glutathione peroxidase
after glucose loading. The absence of an effect on these
systemic markers may suggest that our study was not able to
detect small differences in our limited sample size or that
these markers do not reflect minute changes occurring
within the vascular wall.
Potential mechanisms for the improvement in postpran-
dial endothelial function with vitamins C and E. There
are many theoretical mechanisms whereby vitamins C and E
may have prevented postprandial changes in endothelial
function in our study. Importantly, our study design does
not allow us to differentiate the effects of vitamin C over
vitamin E although, theoretically, their effects may be
synergistic (35). It has been suggested that “antioxidant”
vitamins may improve endothelial function by quenching
superoxide anion, thereby preventing NO inactivation (27).
However, this is unlikely, as the rate constants for the
interaction between vitamins C and E and superoxide are
significantly lower than those for the reaction between
superoxide anion and NO (36). Alternatively, vitamins C
and E may prevent low-density lipoprotein oxidation (37).
Oxidized low-density lipoprotein can directly inactivate NO
Table 4. Systemic Markers of Oxidative Stress Before and After Oral Glucose Loading, Alone or With Vitamins
Variable 0 h 1 h 2 h 3 h 4 h p Value
Plasma malondialdehyde (nmol/ml)
Glucose 0.98 6 0.29 1.06 6 0.43 0.89 6 0.26 0.94 6 0.30 1.02 6 0.21
Glucose 1 vitamins 1.06 6 0.34 1.00 6 0.34 0.92 6 0.31 0.92 6 0.30 0.93 6 0.28 0.15
Erythrocyte glutathione (mM/g Hb)
Glucose 3.1 6 0.6 3.2 6 0.6 3.0 6 0.5 3.1 6 0.7 3.1 6 0.6
Glucose 1 vitamins 3.0 6 0.7 3.1 6 0.8 3.1 6 0.6 3.2 6 0.8 3.0 6 0.8 0.34
Erythrocyte glutathione
peroxidase (U/g Hb)
Glucose 42.2 6 22.7 39.5 6 19.1 41.7 6 20.7 43.3 6 18.7 44.9 6 17.1
Glucose 1 vitamins 42.3 6 20.9 39.2 6 18.5 36.6 6 17.9 41.6 6 21.2 37.6 6 15.7 0.25
Erythrocyte SOD (U/g Hb)
Glucose 728 6 98 670 6 69 708 6 100 681 6 96 735 6 155
Glucose 1 vitamins 679 6 79 691 6 157 696 6 93 682 6 107 679 6 122 0.37
Hb 5 hemoglobin; SOD 5 superoxide dismutase.
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and cause endothelial injury (37). Lastly, vitamins C and E
may directly inhibit hyperglycemia-mediated superoxide
anion release from the vascular wall (12,25), thus preventing
the inactivation of NO.
Study limitations. First, as oral glucose loading produced
significant increases in both plasma glucose and insulin
levels, we cannot conclude that the change in FMD was a
result of elevations of plasma glucose rather than insulin.
However, in vitro studies demonstrate that acute hypergly-
cemia itself may cause impaired endothelium-dependent
vasodilation (9,10). Moreover, Williams et al. (18) demon-
strated that the effects of acute hyperglycemia on
endothelium-dependent vasodilation were similar after
blocking insulin release with octreotide, suggesting that
hyperglycemia is likely the culprit. Second, the possibility
that glucose loading caused a nonspecific loss of smooth
muscle cell function cannot be excluded because we did not
specifically measure endothelium-independent nitroglycerin-
mediated dilation in our study. However, previous studies
have shown that oral glucose loading had no effect on
nitroglycerin-mediated dilation (19,20), suggesting that our
observed effects are more likely to be endothelium-
dependent. Although the study had a limited number of
subjects, measurement of FMD has been shown to be
reproducible with minimal variability over time, which
allows us to use this technique to detect significant differ-
ences in small groups by using each subject as their own
control (38,39). While our baseline FMD (7%) may seem
lower than the “normal” values reported in some previous
studies (30), our values are consistent with other studies of
young healthy subjects using a cuff position below the elbow
(40–42). In premenopausal women, FMD may vary during
the menstrual cycle (43). Although we did not control for
the menstrual cycle phase in female subjects, there was little
variation in their baseline (fasting) FMD measurements on
the two study days.
Clinical implications and conclusions. Our results dem-
onstrate that oral glucose loading transiently attenuates
endothelium-dependent vasodilation in healthy humans
without diabetes, which can be prevented by the coadmin-
istration of vitamins C and E. The clinical relevance of these
findings may be emphasized by epidemiologic studies that
have shown that postprandial hyperglycemia at levels well
below the cutoff for diabetes or IGT is a risk factor for
cardiovascular disease. As endothelial dysfunction is a key
event in atherogenesis, our findings suggest that there may
be a role for vitamin C and E supplementation in preventing
daily postprandial insults to endothelial function, which
may eventually contribute to atherosclerotic vascular disease.
However, further studies assessing the long-term effects of
vitamin supplementation on postprandial endothelial func-
tion and cardiovascular disease are required.
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